Navigation Links
Life Technologies and ProBioGen AG Announce Freedom™ Cell Line Development Royalty-Free Kits To Advance Early Stage Biologic Drug Production
Date:5/17/2011

l property estates in the life sciences industry, with approximately 3,900 patents and exclusive licenses.  For more information on how we are making a difference, please visit our website: http://www.lifetechnologies.com.  Follow Life Technologies on Twitter @LIFECorporation and on Facebook.

About ProBioGen AG

ProBioGen is a renowned Contract Development and Manufacturing Organization (CDMO) and Technology Provider, focusing on cell line engineering, process development (upstream- and downstream) and GMP manufacturing of biopharmaceuticals. ProBioGen's royalty-free, fee-for-service- based CHO platform is based on almost 20 years of experience in mammalian cell culture. Combined with its innovative scientific excellence and strong intellectual property base, ProBioGen covers the entire drug development value chain, including regulatory support for IND-filing. All of ProBioGen's services and technologies are embedded in a total quality management system to assure compliance with international ISO and GMP standards (EMA/FDA). ProBioGen was founded in 1994 and is located in Berlin, Germany.

Life Technologies' Safe Harbor Statement

This press release includes forward-looking statements about Life Technologies' anticipated results that involve risks and uncertainties. Some of the information contained in this press release, including, but not limited to, statements as to industry trends and Life Technologies' plans, objectives, expectations and strategy for its business, contains forward-looking statements that are subject to risks and uncertainties that could cause actual results or events to differ materially from those expressed or implied by such forward-looking statements. Any statements that are not statements of historical fact are forward-looking statements
'/>"/>

SOURCE Life Technologies Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Palatin Technologies, Inc. Reports Third Quarter Fiscal Year 2011 Results
2. Palatin Technologies, Inc. Announces Results of Annual Stockholders Meeting
3. Life Technologies Employees Give Back to Their Communities During Eighth Annual Global Volunteer Day
4. Micell Technologies Reports Preclinical Data for MiStent™ Drug-Eluting Coronary Stent to be Presented at EuroPCR
5. Terumo Americas Holding, Inc., Agrees to Acquire Harvest Technologies Corporation, a Leader in the Development of Point-of-Care Cellular Therapy
6. BioSpecifics Technologies Corp. Reports First Quarter 2011 Financial Results
7. Netsmart Technologies Names Michael Valentine as Chief Executive Officer
8. Caliper Owners Group and Investor Meeting to Highlight Technologies Enabling Personalized Medicine
9. Reportlinker Adds Biomarkers: Technologies and Global Markets
10. Reportlinker Adds Medical Enzymes: Technologies and Global Markets
11. Life Technologies Names Dr. Ora Hirsch Pescovitz to its Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... (PRWEB) March 30, 2015 With recent ... provided you the government, major companies are getting into ... governments setting future mandates for renewable energy production, many ... option. , Solara Power is a new solar distribution ... programs available that allow qualifying homeowners to enjoy the ...
(Date:3/30/2015)... & Struggles (Nasdaq: HSII ), the premier provider of ... culture shaping worldwide, today  announced that John Mitchell ... and Life Sciences practice. As Global Practice Managing ... team of more than 80 partners, principals and associates in ... Asia serving clients in the biopharmaceutical, medical technology ...
(Date:3/30/2015)... March 30, 2015 US-Australian drug discovery company, ... subsidiary, CanTx, Inc., and Yale University, on March 27 ... data was presented as an oral presentation by Professor ... School to the 62 nd Annual Scientific Meeting ... San Francisco, CA. In both ...
(Date:3/30/2015)... GERMANTOWN, Md. , March 30, 2015  /PRNewswire/ ... a leader in synthetic biology, and Merck Serono, ... Germany , today announced an exclusive ... commercialize Chimeric Antigen Receptor T-cell (CAR-T) cancer therapies. ... to develop innovative therapies that modulate the immune ...
Breaking Biology Technology:Solara Power Announces Residential Solar Power with No Up-Front Fees 2Heidrick & Struggles Strengthens Leadership of Healthcare - Life Sciences Practice 2Yale University and Novogen Release Data on Cantrixil Mode of Action 2Yale University and Novogen Release Data on Cantrixil Mode of Action 3Yale University and Novogen Release Data on Cantrixil Mode of Action 4Intrexon and Merck Serono Announce Agreement for the Development and Commercialization of CAR-T Therapy 2Intrexon and Merck Serono Announce Agreement for the Development and Commercialization of CAR-T Therapy 3Intrexon and Merck Serono Announce Agreement for the Development and Commercialization of CAR-T Therapy 4
... , , , NORCROSS, Ga., June 26 ... instrument-reagent systems to the blood transfusion industry, announced that yesterday ... based on an early January 2009 inspection, issued a notice ... to its Reagent Red Blood Cells and Anti-E (Monoclonal) Blood ...
... 26 Syngenta Biotechnology, Inc. announced today that it ... focusing on identifying plant genes related to soybean nematode ... rights to candidate genes discovered by Evogene for use ... soil parasite which attacks the roots of developing plants, ...
... ... synthesis lab and synthetic organic chemist - heating and cooling without an additional cryostat. ... chemistry development tool that requires no training, EasyMax™, and the chance to WIN A SKI ... ...
Cached Biology Technology:Immucor Responds To FDA Notice 2Syngenta and Evogene to Collaborate on Soybean Nematode Resistance 2Register to Win a Ski Weekend and Make Your Synthesis Easier with EasyMax™: the First Automated Chemistry Development Tool That Requires No Training 2
(Date:3/31/2015)... March 31, 2015  Elephant Talk Communications Corp. (NYSE ... provider of Software Defined Network Architecture (ET Software DNA® ... revenue of approximately $20.4 million for the year ended ... million for the year ended December 31, 2013. ... Company had completed its multi-year transition away from its ...
(Date:3/31/2015)... YORK , March 31, 2015   Guidepoint ... the launch of the Post-Surgical Pain Management TRACKER, part ... products tracking usage trends in the medical device and ... access to data including treatment volumes, market share, and ... the pain associated with joint surgery. The ...
(Date:3/30/2015)... Research and Markets ( http://www.researchandmarkets.com/research/lc9bnl/global_gesture ) ... Recognition Market in Automotive Sector 2014-2018" report to ... Gesture Recognition market in Automotive Sector to grow at ... Gesture recognition is the ability of a device ... individual. Gesture recognition technology can be 2D-based or 3D-based. ...
Breaking Biology News(10 mins):Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 2Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 3Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 4Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 5Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 6Guidepoint Launches Post-Surgical Pain Management TRACKER 2Guidepoint Launches Post-Surgical Pain Management TRACKER 3Global Gesture Recognition Market in Automotive Sector Report 2015 - Growing Number of Partnerships 2
... searchable database known as "Threatened ... was developed by a team ... of Florida, the U.S. Fish ... Geological Survey, and the National ...
... create a sustainable food system; studying urban heat ... mountain landscapes are all topics of new grants ... Science Foundation,s (NSF) Science, Engineering and Education for ... NSF,s SEES-Research Coordination Networks (RCN) program. Grants ...
... Ga. Obesity is a major contributor to heart disease ... a cardiologist researching the impact of obesity and weight loss ... demographic group, the country,s problem is only going to get ... of the Medical College of Georgia Section of Cardiology at ...
Cached Biology News:Maintaining Earth's sustainability: Scientists, engineers, educators take coordinated approach 2Maintaining Earth's sustainability: Scientists, engineers, educators take coordinated approach 3Obesity is major contributor to heart disease, impediment to diagnosis and treatment 2Obesity is major contributor to heart disease, impediment to diagnosis and treatment 3
...
Anti-VDAC (Voltage-Dependent Anion Channel) AVOID FREEZE/THAW CYCLES. Recognizes the porin 31HL protein. Corresponds to mAb 1 in the literature....
This spacer is required to use the Miniature FRENCH Pressure Cell (FA-003) with the Laboratory Press....
... Amplification Grade digests single- ... oligodeoxyribonucleotides. The specific activity ... I Amplification Grade is ... for absence of RNase ...
Biology Products: